226 related articles for article (PubMed ID: 3102353)
21. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
Saxena RK; Adler WH
J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
[TBL] [Abstract][Full Text] [Related]
22. A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity.
Halloran P; Schirrmacher V; Festenstein H
J Exp Med; 1974 Nov; 140(5):1348-63. PubMed ID: 4547657
[TBL] [Abstract][Full Text] [Related]
23. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
Saxena RK; Saxena QB; Adler WH
Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
[TBL] [Abstract][Full Text] [Related]
24. Lack of association of human "B cell" antigens and Fc receptor activity of antibody-dependent cytotoxic lymphocytes.
Miller JL; Humphreys RE; Mann DL
J Immunol; 1976 Aug; 117(2):491-6. PubMed ID: 781131
[TBL] [Abstract][Full Text] [Related]
25. Local activation of the killing mechanism in PU5 antibody-dependent cell-mediated cytotoxicity effector cells.
Wei WZ; Lindquist RR
J Immunol; 1983 Mar; 130(3):1458-61. PubMed ID: 6600483
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.
Flood PM; Murphy DB; Horowitz M; LeClair KP; Smith FR; Stockert E; Palladino MA; DeLeo AB
J Immunol; 1985 Jul; 135(1):63-72. PubMed ID: 2987354
[TBL] [Abstract][Full Text] [Related]
27. Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.
Shiku H; Kisielow P; Bean MA; Takahashi T; Boyse EA; Oettgen HF; Old LJ
J Exp Med; 1975 Jan; 141(1):227-41. PubMed ID: 1078839
[TBL] [Abstract][Full Text] [Related]
28. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of antibody-dependent cellular cytotoxicity by autologous lymph node cells.
Pollack SB; Herrick MV
J Immunol; 1977 Dec; 119(6):2172-8. PubMed ID: 303260
[TBL] [Abstract][Full Text] [Related]
30. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
31. T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction.
Basten A; Miller JF; Loblay R; Johnson P; Gamble J; Chia E; Pritchard-Briscoe H; Callard R; McKenzie IF
Eur J Immunol; 1978 May; 8(5):360-70. PubMed ID: 308454
[TBL] [Abstract][Full Text] [Related]
32. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
Greenberg AH; Shen L; Medley G
Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
[TBL] [Abstract][Full Text] [Related]
34. Cooperation of IgG monoclonal antibodies in macrophage antibody-dependent cellular cytotoxicity (ADCC) to tumor targets.
Ralph P; Nakoinz I
J Leukoc Biol; 1984 Jan; 35(1):131-9. PubMed ID: 6584510
[TBL] [Abstract][Full Text] [Related]
35. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
36. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions.
Macphail S; Stutman O
J Immunol; 1987 Dec; 139(12):4007-15. PubMed ID: 2961804
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes.
Ralph P; Nakoinz I
J Immunol; 1983 Aug; 131(2):1028-31. PubMed ID: 6134771
[TBL] [Abstract][Full Text] [Related]
38. Palmitate-derivatized antibodies can specifically "arm" macrophage effector cells for ADCC.
Colsky AS; Peacock JS
J Leukoc Biol; 1991 Jan; 49(1):1-7. PubMed ID: 1984483
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
40. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
